The 2016 American Society for Microbiology-Microbe (ASM Microbe 2016) was an August meeting held in the magnificent city of Boston at the Boston Convention and Exhibition Center (BCEC) and its high-traffic neighborhood from June 16-20. It is the first time that the ASM general meeting and the ICAAC (Interscience Conference On Antimicrobial Agents And Chemotherapy) merged to make a single giant convention. This year the meeting saw huge participation from academia, the pharmaceutical industry, and several biotechs. There were big brands as well as smaller start-ups in the microbial horizon clamoring for attention amongst the 7000-odd attendees. Indeed, in the words of David C. Hooper, MD; Massachusetts General Hospital and Chair, ASM Meetings Board-“It’s really the only meeting of its kind. It covers the scope of microbiology and microbial sciences from A to Z, from basic to clinical applications”. The event kick-started with a Conversation with Bill Gates: Bringing the Frontiers of Science to the Front Lines of Development that rightfully set the tone for the rest of the conference. The tech mogul championed the cause for prevention and cure for several infectious diseases across the globe, especially in developing countries. He highlighted the need for more microbe-oriented research to eradicate the menace of infectious diseases.
The main event was divided into several parallels running scientific tracks and workshops conducted by experts in the field. From the pharma standpoint, sessions that focused on host-microbe ecology, the translational aspect of microbial research and therapeutics and prevention were my top choices. Clostridium difficile infection, HIV cure, dysbiosis and rebiosis, fecal matter transplant, prebiotics and probiotics, microbiome interaction, inflammation were some of the buzzwords from these sessions. It is perhaps not out of context to mention that my work on the discovery of microbial metabolite mimics was very well received and had the floor cheering. GSK’s unique approach towards ‘Microbiome-to- Targets’ was lauded at all levels. Several stalwarts in the field of microbiome research like Robert Knight (University of California, San Diego), Peter Turnbaugh (University of California, San Francisco), Andrew Goodman (Yale University), Laurie E. Comstock (Harvard University), were also present in the audience. I had an opportunity to a have a talk on my research work which featured in the “Influence of Microbial Products on the Gut Microbiota or Host” symposium.
The wealth of information amassed from the Human Microbiome Project (http://hmpdacc.org/) needs processing, in-depth analysis, development of new Bioinformatics tools and software to meaningfully interpret the microbiome association in human health and their clinical implications. Sequencing of the 16S rRNA regions from the commensal microbes bypassed the challenges of identifying bacteria from cultures (most of the commensals from different body sites are actually still uncultivable in the lab). At ASM, scientists from various disciplines were unequivocal in stressing the need for more microbiome research given the intricate biology of host-microbe interaction. Understanding the molecular mechanism of this “cross-talk” is still in its infancy, emphasizing the need for more pharma investment in this area to develop new therapeutic products. As increasing number of evidence points to the involvement of the commensal microbiota in several autoimmune disorders, metabolic diseases, respiratory diseases, and neurological disorders, it is only logical to study bugs that are our “buddies” as well as the ones that are “baddies”. In conclusion, the microbiome market will only gain traction in near future.
Somdutta Saha, Ph.D.
Early Talent Postdoctoral fellow,
Computational Biology, R&D, GlaxoSmithKline,
1250 South Collegeville Road, Collegeville. Pennsylvania 19426.
Disclaimer: The views expressed in this article are that of the author’s alone and not necessarily endorsed by GlaxoSmithKline(GSK) Plc.
Proteins shape analyses reveal novel forms and connections.
A new study has revealed new forms of proteins that have never been seen before along with unexpected connections. Last year, Google DeepMind predicted the structure of all known proteins from organisms using AlphaFold .
What is MANE project?
MANE is a collaborative project between NCBI and EMBL-EBI. It stands for Matched Annotation from NCBI and EMBL-EBI . The datasets provided by NCBI and EMBL-EBI on the human genome are not identical across every gene.
This Month in Bioinformatics- Research Updates of March 2022
This month in Bioinformatics- Research Updates of November 2021
This Month in Bioinformatics- Research Updates of October 2021
BLAST+ 2.12.0- A more efficient version of BLAST is available
This Month in Bioinformatics- Research Updates of June 2021
This Month in Bioinformatics- Research Updates of May 2021
This Month in Bioinformatics- Research Updates of April 2021
This Month in Bioinformatics- Research Updates of March 2021
This Month in Bioinformatics- Research Updates of February 2021
This Month in Bioinformatics- Research Updates of January 2021
This Month in Bioinformatics- Research Updates of December 2020
Join Bioinformatics Review Research Group
This Month in Bioinformatics- Research Updates of November 2020
This Month in Bioinformatics- Research Updates of October 2020
This Month in Bioinformatics: Research Updates of September 2020
This Month in Bioinformatics: Research Updates of August 2020
This month in Bioinformatics: Research Updates of July 2020
Inviting Nominations for ‘Top 5 Bioinformaticians in India 2020’
Bioinformatics Review compiles a list of top bioinformaticians every two years. We are inviting nominations for the second edition of this award after the 2018 List. We invite you to contribute to this endeavor by nominating your colleague or friends if you think they can make it to our list.
Nominations start from 20th June 2020 till 15th August 2020. All the nominees will be informed via email on 5th September 2020. We use a well-established ranking method called ScipRank. Our data collection is open-source. ScipRank methodology is publicly available for scrutiny.
Also, we are completing 5th year of success in Bioinformatics Review this year. On this occasion, we are organizing an International Conference on Advanced Research in Bioinformatics 2020. The award will be declared at the conclusion of ConARB 2020 – 3 & 4th Oct 2020).
We invite you to contribute to this endeavor by nominating your colleague or friends. You can also submit your papers, which if accepted, can be presented at the conference.
We have set up a dedicated portal for ConARB 2020 accessible here https://conarb.
To attend or to submit your abstract or to nominate someone, kindly visit this website. Accepted papers will be published in a special issue of Bioinformatics Review.